Areas of expertise

Home

Internal Hits : 851
External Hits: 8307
 
File Last modified on: Mon Dec 21, 2020 22:47:23
 

Technologies and Expertise available at IIT Bombay w.r.t COVID-19    Click here

Projects initiated by IIT Bombay for COVID-19 mitigation

Webinar on R&D at IIT Bombay for Covid-19 Mitigation (August 1, 2020)

 
Faculty(Prof.) Expertise Participation Details Projects Initiated Technologies developed/
available for collaboration/
licensing
J. Bellare Nanoparticle based drug delivery, Structure analysis
  • Nanoparticle based drug delivery and formulation (Prof. Bellare; jb@iitb.ac.in)
  • Cryo-Electron microscopy to determine the structure of SARS-CoV-2 spike protein and its cellular receptor during infection. This could be helpful for design of new molecules or in decision on repurposing existing molecules.(Prof. Bellare; jb@iitb.ac.in)
    		•
    K. V. Venkatesh Data driven models
  • Perform drug release studies and determine optimal drug dosage (Prof Venkatesh (venks@iitb.ac.in, Prof. Bellare jb@iitb.ac.in)
  • Analyze and monitor clinical study through systems biology (Prof. Venkatesh; venks@iitb.ac.in)
    		•
    Ravindra Gudi Scale up models
  • Assist in scale up through models and also data driven models (Prof. Venkatesh venks@iitb.ac.in, Prof. Gudi ravigudi@iitb.ac.in)
    		•
    Pradeep Kumar P.I Targeted therapy development
  • Targeting non-canonical structures of COVID-19 genomic RNA by small-molecule ligands;
  • Developing functional nucleic acids like aptamers/siRNAs /antisense oligos against COVID-19 proteins
    		•
    Sanjeeva Srivastava

    Collaborators: Dr.Om Shrivastav, Jaslok Hospital Dr. Jayanthi S. Shastri, (T N Medical College & Nair Hospital) Specialist at Kasturba, Nair & Jaslok Hospitals.     		Proteomic analysis
  • Proteomic analysis
    		•
  • Identification of global metabolite biomarkers in COVID-19 infected patients for targeted therapy
  • Plasma Proteomic Analysis of COVID-19 patients to identify the potential biomarkers and therapeutic targets
    		•
    Rinti Banerjee Expertise in biomaterials, encapsulation technology, drug delivery and nanomedicine
  • Development of drug delivery platforms for sustained delivery of antiviral drugs for oral, buccal, nasal, aerosol routes
  • Development of nanoparticle adjuvants for vaccine delivery
  • Development of high absorption nutraceutical formulations including solubilisation of water insoluble bioactives
  • Development of dissolvable microneedle platforms for vaccine delivery
  • Development of oral and dermal formulations for delivery of nutrients for enhanced immunity
    		•
  • Aerosols for Acute Respiratory Distress Syndrome complications of COVID 19
  • Nutraceutical with antiviral and anti-inflammatory properties
    		•